Banerjee M - Search Results

1

The role of clinicians in determining radioactive iodine use for low-risk thyroid cancer.

Haymart MR, Banerjee M, Yang D, Stewart AK, Koenig RJ, Griggs JJ. Haymart MR, et al. Among authors: banerjee m. Cancer. 2013 Jan 15;119(2):259-65. doi: 10.1002/cncr.27721. Epub 2012 Jun 28. Cancer. 2013. PMID: 22744940 Free PMC article.

2

Recursive partitioning for prognostic grouping of patients with clinically localized prostate carcinoma.

Banerjee M, Biswas D, Sakr W, Wood DP Jr. Banerjee M, et al. Cancer. 2000 Jul 15;89(2):404-11. Cancer. 2000. PMID: 10918173

3

Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinoma.

Wei S, Kryczek I, Edwards RP, Zou L, Szeliga W, Banerjee M, Cost M, Cheng P, Chang A, Redman B, Herberman RB, Zou W. Wei S, et al. Among authors: banerjee m. Cancer Res. 2007 Aug 1;67(15):7487-94. doi: 10.1158/0008-5472.CAN-07-0565. Cancer Res. 2007. PMID: 17671219 Clinical Trial.

4

Disentangling the effects of race on breast cancer treatment.

Banerjee M, George J, Yee C, Hryniuk W, Schwartz K. Banerjee M, et al. Cancer. 2007 Nov 15;110(10):2169-77. doi: 10.1002/cncr.23026. Cancer. 2007. PMID: 17924374 Free article.

5

A prospective study of aromatase inhibitor-associated musculoskeletal symptoms and abnormalities on serial high-resolution wrist ultrasonography.

Henry NL, Jacobson JA, Banerjee M, Hayden J, Smerage JB, Van Poznak C, Storniolo AM, Stearns V, Hayes DF. Henry NL, et al. Among authors: banerjee m. Cancer. 2010 Sep 15;116(18):4360-7. doi: 10.1002/cncr.25385. Cancer. 2010. PMID: 20549827 Free PMC article.

6

Pilot study of duloxetine for treatment of aromatase inhibitor-associated musculoskeletal symptoms.

Henry NL, Banerjee M, Wicha M, Van Poznak C, Smerage JB, Schott AF, Griggs JJ, Hayes DF. Henry NL, et al. Among authors: banerjee m. Cancer. 2011 Dec 15;117(24):5469-75. doi: 10.1002/cncr.26230. Epub 2011 Jun 20. Cancer. 2011. PMID: 21692065 Free article. Clinical Trial.

7

Use of radioactive iodine for thyroid cancer.

Haymart MR, Banerjee M, Stewart AK, Koenig RJ, Birkmeyer JD, Griggs JJ. Haymart MR, et al. Among authors: banerjee m. JAMA. 2011 Aug 17;306(7):721-8. doi: 10.1001/jama.2011.1139. JAMA. 2011. PMID: 21846853 Free PMC article.

8

Factors that influence radioactive iodine use for thyroid cancer.

Papaleontiou M, Banerjee M, Yang D, Sisson JC, Koenig RJ, Haymart MR. Papaleontiou M, et al. Among authors: banerjee m. Thyroid. 2013 Feb;23(2):219-24. doi: 10.1089/thy.2012.0380. Thyroid. 2013. PMID: 23134514 Free PMC article.

9

Trends in advanced imaging use for women undergoing breast cancer surgery.

Breslin TM, Banerjee M, Gust C, Birkmeyer NJ. Breslin TM, et al. Among authors: banerjee m. Cancer. 2013 Mar 15;119(6):1251-6. doi: 10.1002/cncr.27838. Epub 2012 Dec 4. Cancer. 2013. PMID: 23212691 Free article.

10

Surgeon training and use of radioactive iodine in stage I thyroid cancer patients.

Schuessler KM, Banerjee M, Yang D, Stewart AK, Doherty GM, Haymart MR. Schuessler KM, et al. Among authors: banerjee m. Ann Surg Oncol. 2013 Mar;20(3):733-8. doi: 10.1245/s10434-012-2745-0. Epub 2012 Dec 6. Ann Surg Oncol. 2013. PMID: 23224826 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,478 results

Search Page

Filters